Analysis of the serum ApoB protein levels in patients after the first demyelinating event also showed a direct correlation with the number of T2 lesions developed after 2 years, and its upregulation is correlated with increased disability in MS patients [70–72]. The gene discussed is APOB; the disease is myeloid sarcoma.